Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label immunotherapy. Show all posts
Showing posts with label immunotherapy. Show all posts
Monday, June 18, 2012

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy

›
Published: 18 June 2012 (This article belongs to the Special Issue Cancer Vaccines and Immunotherapy ) Download PDF Full-Text   ...
Monday, May 28, 2012

Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation

›
Complete clinical responses to cancer therapy caused by multiple diver Complete clinical responses to cancer therapy caused by multiple...
Saturday, May 19, 2012

paywalled: Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.

›
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen. : Abstract Immunotherapy for ovarian cancer is one of the n...
Thursday, May 10, 2012

Immunotherapy of cancer in 2012 - Kirkwood - 2012 - CA: A Cancer Journal for Clinicians - Wiley Online Library

›
Immunotherapy of cancer in 2012 - Kirkwood - 2012 - CA: A Cancer Journal for Clinicians excerpt re: ovarian cancer: Immunotherapy fo...
Monday, May 07, 2012

Insight: Training immune system to fight cancer comes of age | Reuters

›
 Blogger's Note: not specific to ovarian cancer Insight: Training immune system to fight cancer comes of age | Reuters ".....W...
Friday, February 24, 2012

NCI Cancer - Clinical Trials Network Aims to Strengthen Cancer Immunotherapy Pipeline

›
"Later this year, the first clinical trials will be launched under a new NCI-funded initiative to spur the development of cancer trea...
Saturday, August 06, 2011

Cancers | Free Full-Text | Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines (including ovarian cancer)

›
Download PDF Full-Text [270 KB, uploaded 5 August 2011 17:58 CET]
Tuesday, June 07, 2011

press release: Quest PharmaTech Provides Chemo Immunotherapy Clinical Trial update (Italy)

›
Wednesday, February 16, 2011

summary: Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer phase 111 MIMOSA trial

›
Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer Rachel N Grisham ​‌ 1 , Jonathan Berek ​‌ 2 , Jac...
Wednesday, September 22, 2010

full free access: Investigating Better Endpoints for Immunotherapy Trials — J. Natl. Cancer Inst.

›
Saturday, September 18, 2010

Antigen-specific active immunotherapy for ovarian cancer

›
              " " Information on adverse events was frequently limited." PLAIN LANGUAGE SUMMARY: Epithelial ovarian can...
Wednesday, June 09, 2010

Future Oncology -- Full Text - Cancer immunotherapy: focusing on the young, neglecting the old

›
"...Undoubtedly we should pay more attention to the effect that aging has on the immune system. To optimally stimulate an anti-tumor i...
Friday, April 30, 2010

FDA Approval For Dendreon Provenge Immunotherapy Vaccine - pharma news/Australia "CVac"

›
"Dendreon is using cancer immunotherapies that use the patient's own immune system to treat cancer and the approval of Provenge rep...
Monday, April 26, 2010

Ontario Institute for Cancer Research Announces Three New Equity Investments -- TORONTO, April 26 /PRNewswire/ --

›
Note: press release has further information on the investments: 1)Novel Cellular Immunotherapy for Cancer; 2)Next Generation Biomarker A...
Monday, March 29, 2010

full free access: The detection, treatment, and biology of epithelial ovarian cancer

›
Note: click on 'pdf' for access to the full paper Review The detection, treatment, and biology of epithelial ovarian cancer Je...
Tuesday, March 23, 2010

Stanford University Researcher and Hemispherx Biopharma Consultant Present New Integrative Immunotherapy Approach - news item

›
"PHILADELPHIA, Mar 23, 2010 (GlobeNewswire via COMTEX) -- Hemispherx Biopharma, Inc. announced today the publication of an editorial en...
Wednesday, March 10, 2010

full free access: Journal of Hematology & Oncology - Ovarian cancer immunotherapy: opportunities, progresses and challenges

›
"Abstract Due to the low survival rates from invasive ovarian cancer, new effective treatment modalities are urgently needed. Compell...
Monday, February 08, 2010

Enhancing adoptive immunotherapy of cancer; Expert Opinion on Biological Therapy

›
Friday, January 29, 2010

Immunotherapy of Cancer: Key Findings and Commentary on the Third Tegernsee Conference -2009- The Oncologist

›
*the Oncologist now requires a subscription $$/abstracts available for free